Navigation Links
Murrieta Genomics and SeqOnce Biosciences Team to Simplify and Commercialize Next Generation Sequencing Sample Preparation
Date:2/22/2019

Murrieta Genomics, the genomic sequencing business incubator and SeqOnce, an emerging leader in the rapidly growing NGS (Next Generation Sequencing) field, have announced a partnership to bring fast and simple sample solutions for the Murrieta Genomics laboratory and incubator.

"As an innovation center and idea incubator, we are always looking for new applications in the genomic sequencing space and the RhinoSeq™ kits from SeqOnce have huge promise,” stated Brandon Young, a co-founder of Murrieta Genomics and the company’s Director of Laboratory Operations. “RhinoSeq is a remarkably fast and easy-to-use product for library preparation that will disrupt the growing NGS market. We see Rhinoseq reducing library construction time from a multi-hour process to less than 45 minutes, producing consistently excellent results across a wide range of sample types and inputs. We are excited to team with SeqOnce to develop, showcase and demonstrate their libraries to our growing base of customers and incubator companies."

“The proprietary chemistry in RhinoSeq reduces the preparation time of NGS samples by several fold over other library preparation methods,” explained SeqOnce CEO Chris Angermayer. “The technology can be applied to DNA from any sample source and can be adapted to most sequencing applications and automation platforms. Having access to the Murrieta Genomics lab and its partners provides us with new development and distribution opportunities.”

Under the agreement, Murrieta Genomics will showcase SeqOnce’s technology and products in the incubator facility, providing information and demonstrations to potential customers. Murrieta Genomics will also assist SeqOnce with product development by testing and using its products in the Murrieta laboratory.
The fact that Murrieta Genomics will be sequencing genetic material from diverse sources across multiple applications was a plus for SeqOnce. “We really like that Murrieta Genomics accesses and advances a broad range of genomic sequencing technologies, as this approach fits perfectly with our concept of developing robust sample preparation libraries,” Angermayer concluded.

About Murrieta Genomics
Murrieta Genomics provides access to next generation sequencing technology for researchers in the health, veterinary, agriculture, forensics and direct to consumer industries. The company is a true business incubator, offering mentorship and guidance from both the scientific and business perspective to aspiring genomic-related entrepreneurs. The founders of Murrieta Genomics have extensive background in business, finance, science and technology. They are supplemented with a prestigious advisory board from both business and science. In addition to low-cost incubation, the company provides hands-on consulting and will provide seed funding to qualified incubator graduates and connections to next-stage funders. For more information visit http://www.murrietagenomics.com.

About SeqOnce Biosciences, Inc.
SeqOnce Biosciences is a life science company developing innovative products for Next Generation Sequencing (NGS) that addresses critical needs in the research and clinical markets. Additional technologies and novel products for NGS library construction applications are pipelined and undergoing validation. Learn more at http://www.seqonce.com

Read the full story at https://www.prweb.com/releases/murrieta_genomics_and_seqonce_biosciences_team_to_simplify_and_commercialize_next_generation_sequencing_sample_preparation/prweb16115417.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. Genomics Data Management Leader Annai Systems Offers Shortcut to Analysis
2. BGI-Shenzhen Completes Acquisition of Complete Genomics
3. Squished bug genomics: Insect goo aids biodiversity research
4. Rosetta Genomics Announces Poster Presentations at AACR Annual Meeting 2013
5. Venter Institute-Led Team Recovers and Sequences Genome of Periodontal Pathogen from Biofilm in Hospital Sink using Single-Cell Genomics
6. Real Time Genomics and Omicia Partner on a Platform for Integrated Genomic Analysis for Childhood Disease
7. Rosetta Genomics Reaches Settlement Agreement with Sanra Laboratories in Connection with Previous Sale of Parkway Clinical Laboratories
8. Nimbix and Convey Partner for “The Accelerated Genomics Cloud” (TAGC) Promotion
9. Real Time Genomics and J. Craig Venter Institute Embark on Strategic Research Initiative
10. Real Time Genomics and Knome Ink Deal to Integrate and Sell the RTG Variant Platform on knoSYS100 System
11. Real Time Genomics Secures a $5 Million Round of Funding to Expand Commercial Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2020)... (PRWEB) , ... April 21, 2020 , ... ... continue their work through COVID-19. Many clinical trial teams are working remotely and ... Ripple Science wants to help researchers continue their research during this uncertain time ...
(Date:4/1/2020)... ... March 30, 2020 , ... ... product, ArmourGuard® RTU, an EPA-approved spray-on antimicrobial solution. As a first-of-its-kind technology within ... provides continual antimicrobial activity against microorganisms for up to 90 days. , In ...
(Date:4/1/2020)... ... March 31, 2020 , ... ... announce the signing of a Joint Development Agreement that builds on each company’s ... is a global leader in the supply of high-quality insect pheromones as well ...
(Date:3/19/2020)... ... March 18, 2020 , ... ... bio signals to provide rapid insight into their perceptions of events. Imagine if ... the other. What if they could measure the level of engagement of each ...
Breaking Biology Technology:
(Date:5/14/2020)... ... May 12, 2020 , ... ... that helps Life Science Manufacturers accurately and easily project contracted liabilities with ... of Gross-to-Net models by projecting discounts/rebates to Commercial and Government entities, Copay ...
(Date:5/14/2020)... , ... May 14, 2020 , ... ... board for medical sales representatives, found the 2019 average medical sales rep total ... risk being shadowed by uncertainties amid the COVID-19 global crisis. , The MedReps ...
(Date:5/6/2020)... Md. and LEXINGTON, Mass. (PRWEB) , ... May 06, 2020 , ... ... Hemanext Inc. , a privately held medical technology company dedicated to improving the quality, ... announce a new partnership that will help SCDAA deliver on its mission and meet ...
Breaking Biology News(10 mins):